Signal transduction by human NK cell MHC-recognizing receptors

Immunological Reviews

Volumn 155, Issue , 1997, Pages 197-203

  Binstadt, Bryce A ^a   Brumbaugh, Kathryn M ^a   Leibson, Paul J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; CELL RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; CELL MEDIATED CYTOTOXICITY; CELL PROTECTION; GENE DISRUPTION; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0031057435     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb00952.x     Document Type: Review

References (70)

1. Carroll L. Alice's adventures in Wonderland. Boston: Lee and Shepard, 1870.
2. Ljunggren HG, Kärre, K. In search of the missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:7-10.
3. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A. Human natural killer cells: origins, clonality, specificity, receptors. Adv Immunol 1994;55:341-380.
4. Trinchieri G. Recognition of major histocompatibility complex class I antigens by natural killer cells. J Exp Med 1994;180:417-421.
5. Leibson PJ. MHC-recognizing receptors: they're not just for T cells anymore. Immunity 1995;3:5-8.
6. Mingari MC, et al. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol 1995;7:697-703.
7. Phillips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995;268:403-405.
8. Yokoyama WM. Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc Natl Acad Sci USA 1995;92:3081-3085.
9. Colonna M. Natural killer cell receptors specific for MHC class I molecules. Curr Opin Immunol 1996;8:101-107.
10. Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996;17:86-91.
11. Raulet DH. Recognition events that inhibit and activate natural killer cells. Curr Opin Immunol 1996;8:372-377.
12. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:405-408.
13. Wagtmann N, et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995;2:439-449.
14. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypes. J Immunol 1995;155:2306-2310.
15. Döhring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A. J Immunol 1996;156:3098-3101.
16. Pende D, et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide- linked dimer. J Exp Med 1996;184:505-518.
17. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO. Killer cell inhibitory-receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995;3:801-809.
18. Fry AM, Lanier LL, Weiss A. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signalling and for association with protein tyrosine phosphatase 1C. J Exp Med 1996;184:295-300.
19. Moretta A, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995;182:875-884.
20. Biassoni R, et al. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996;183:645-650.
21. Chan AC, Desai DM, Weiss A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol 1994;12:555-592.
22. Burshtyn DN, et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996;4:77-85.
23. Binstadt BA, et al. Sequential involvement of lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. (Manuscript submitted.)
24. lck. Nature 1992;357:161-164.
25. lck. Eur J Immunol 1995;25:3155-3159.
26. Shen SH, Bastien L, Posner BI, Chretien P. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 1991;352:736-739.
27. Yi T, Cleveland JL, Ihle JN. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, localization to human chromosome 12p12-p13. Mol Cell Biol 1992;12:836-846.
28. Plutzky J, Neel BG, Rosenberg RD. Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 1992;89:1123-1127.
29. Matthews RJ, Bowne DB, Flores E, Thomas ML. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, threonine-rich sequences. Mol Cell Biol 1992;12:2396-2405.
30. Zhao Z, Bouchard P, Diltz CD, Shen SH, Fischer EH. Purification and characterization of a protein tyrosine phosphatase containing SH2 domains. J Biol Chem 1993;268:2816-2820.
31. Thomas ML. Positive and negative regulation of leukocyte activation by protein tyrosine phosphatases. Sem Imnumol 1995;7:279-288.
32. Schultz LD, et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993;73:1445-1454.
33. Kozlowski M, Mlinaric-Rascan I, Geng G-S, Shen R, Pawson T, Siminovitch KA. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med 1993;178:2157-2163.
34. Yu CCK, Tsui H-W, Ngan BY, Shulman MJ, Wu GE, Tsui FWL. B and T cells are not required for the viable motheaten phenotype. J Exp Med 1996;183:371-380.
35. Cyster JG, Goodnow CC. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signalling in B lymphocytes and determines thresholds for negative selection. Immunity 1995;2:13-24.
36. Einspahr KJ, Abraham RT, Binstadt BA, Uehara Y, Leibson PJ. Tyrosine phosphorylation provides an early and requisite signal for the activation of natural killer cell cytotoxic function. Proc Natl Acad Sci USA 1991;88:6279-6283.
37. O'Shea JJ, Weissman AM, Kennedy ICS, Ortaldo JR. Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the ζ chain. Proc Natl Acad Sci USA 1991;88:350-354.
38. Ting AT, Einspahr KJ, Abraham RT, Leibson PJ. Fcγ receptor signal transduction in natural killer cells: coupling to phospholipase C via a G protein-independent, but tyroxine kinase-dependent pathway. J Immunol 1991;147:3122-3127.
39. Vivier E, Morin P, O'Brien C, Druker B, Schlossman SF, Anderson P. Tyrosine phosphorylation of the FcγRIII(CD16): ζ complex in human natural killer cells: induction by antibody-dependent cytotoxicity but not by natural killing. J Immunol 1991;146:206-210.
40. O'Shea JJ, McVicar DW, Kuhns DB, Ortaldo JR. A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity: effects of herbimycin A. J Imnumol 1992;148:2497-2502.
41. Olcese L, et al. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol 1996;156:4531-4534.
42. Campbell KS, Dessing M, López-Botet M, Cella M, Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med 1996;184:93-100.
43. lck protein tyrosine kinase with the FcγRIIIA/CD16 complex in human natural killer cells. Eur J Immunol 1993;23:2488-2497.
44. Pignata C, Prasad KVS, Robertson MH, Levine H, Rudd CE, Ritz J. FcyRIIIA-mediated signalling involves src-family lck in human natural killer cells. J Immunol 1993;151:6794-6800.
45. Salcedo TW, Kurosaki T, Kanakaraj P, Ravetch JV, Perussia B. Physical and functional association of p56lck with FcγRIIIA (CD16) in natural killer cells. J Exp Med 1993;177:1475-1480.
46. Vivier E, DaSilva AJ, Ackerly M, Levine H, Rudd CE, Anderson P. Association of a 70-kDa tyrosine phosphoprotein with the CD16: zeta:gamma complex expressed in human natural killer cells. Eur J Immunol 1993;23:1872-1876.
47. Ting AT, Dick CJ, Schoon RA, Karnitz LM, Abraham RT, Leibson PJ. Interaction between lck and syk family tyrosine kinases in Fcγ receptor-initiated activation of natural killer cells. J Biol Chem 1995;270:16415-16421.
48. Windebank KP, Abraham RT, Powis G, Olsen RA, Barna TJ, Leibson PJ. Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP. J Immunol 1988;141:3951-3957.
49. lck activation J Exp Med 1992;176:1745-1750.
50. Ting AT, Karnitz LM, Schoon RA, Abraham RT, Leibson PJ. Fcγ receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC) γ-1 and PLC-γ2 in natural killer cells. J Exp Med 1992;176:1751-1755.
51. Kaufman DS, Schoon RA, Leibson PJ. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. J Immunol. 1993;150:1429-1436.
52. Kaufman DS, Schoon RA, Robertson MJ, Leibson PJ. Inhibition of selective signalling events in natural killer cells recognizing major histocompatibility complex class I. Proc Natl Acad Sci USA 1995;92:6484-6288.
53. Vitale M, Sivori S, Pende D, Moretta L, Moretta A. Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. Proc Natl Acad Sci USA 1995;92:3536-3540.
54. Plas DR, et al. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signalling. Science 1996;272:1173-1176.
55. Lanier LL, Phillips, JH. Triggering structures on NK cells. In Sitkovsky MV, Henkart PA, eds. Cytotoxic cells: recognitions, effector function, generation and methods. Boston: Birkhäuser, 1993:84-95.
56. Bonnema J, Karnitz LM, Schoon RA, Abraham RT, Leibson PJ. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J Exp Med 1994;180:1427-1435.
57. D'Ambrosio D, et al. Recruitment and activation of PTP1C in negative regulation of anti-gen receptor signalling by FcγRIIB1. Science 1995;268:293-297.
58. Ono M, Bolland S, Tempst P, Ravetch JV. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature;383:263-266.
59. D'Andrea A, Chang C, Phillips JH, Lanier LL. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J Exp Med 1996;184:789-794.
60. Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM. Partial T cell signalling: altered phospho-ζ and lack of Zap70 recruitment in APL-induced T cell anergy. Cell 1994;79:913-922.
61. Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 1995;267:515-518.
62. McKeithan TW. Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci USA 1995;92:5042-5046.
63. Lyons DS, et al. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 1996;5:53-61.
64. + T lymphocytes: I. Inhibition of the IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol 1990;144:3238-3247.
65. + T lymphocytes: II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J Immunol 1991;147:714-721.
66. Chang C, Rodríguez A, Carretero M, López-Botet M, Phillips JH, Lanier LL. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995;25:2433-2437.
67. Moretta A, et al. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 1995;180:545-555.
68. Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL. CD94 and a novel associated protein (94AP) form an NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 1996;5:163-172.
69. Pérez-Villar JJ, et al. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 1995;154:5779-5788.
70. Brumbaugh KM, Pérez-Villar JJ, Dick CJ, Schoon RA, López-Botet M, Leibson PJ. Clonotypic differences in signalling from CD94 (Kp43) on NK cells lead to divergent cellular responses. J Immunol 1996;157:2804-2812.